High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody.

MLA

Allenbach, Yves, et al. “High Risk of Cancer in Autoimmune Necrotizing Myopathies: Usefulness of Myositis Specific Antibody.” Brain: A Journal of Neurology, vol. 139, no. 8, Aug. 2016, pp. 2131–35. EBSCOhost, https://doi.org/10.1093/brain/aww054.

APA

Allenbach, Y., Keraen, J., Bouvier, A., Jooste, V., Champtiaux, N., Hervier, B., Schoindre, Y., Rigolet, A., Gilardin, L., Musset, L., Charuel, J.-L., Boyer, O., Jouen, F., Drouot, L., Martinet, J., Stojkovic, T., Eymard, B., Laforêt, P., Behin, A., & Salort-Campana, E. (2016). High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody. Brain: A Journal of Neurology, 139(8), 2131–2135. https://doi.org/10.1093/brain/aww054

Chicago

Allenbach, Yves, Jeremy Keraen, Anne-marie Bouvier, Valérie Jooste, Nicolas Champtiaux, Baptiste Hervier, Yoland Schoindre, et al. 2016. “High Risk of Cancer in Autoimmune Necrotizing Myopathies: Usefulness of Myositis Specific Antibody.” Brain: A Journal of Neurology 139 (8): 2131–35. doi:10.1093/brain/aww054.